{
    "2021-12-16": [
        [
            {
                "time": "2021-12-01",
                "original_text": "Why Moderna and Pfizer Beat the Market Today",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Pfizer",
                        "Beat",
                        "Market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-02",
                "original_text": "CDC Advisors Recommend Pfizer and Moderna’s Vaccines Over J&J’s",
                "features": {
                    "keywords": [
                        "CDC",
                        "Advisors",
                        "Recommend",
                        "Pfizer",
                        "Moderna",
                        "Vaccines",
                        "J&J"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-03",
                "original_text": "UPDATE 1-Pfizer files for full FDA approval of COVID-19 vaccine in adolescents",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "FDA",
                        "Approval",
                        "COVID-19",
                        "Vaccine",
                        "Adolescents"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "regulatory"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-04",
                "original_text": "Doctor says 'We have to prepare for a surge' amid the Omicron variant's surge",
                "features": {
                    "keywords": [
                        "Doctor",
                        "Prepare",
                        "Surge",
                        "Omicron",
                        "Variant"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "epidemiology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-05",
                "original_text": "EMA Offers Early Access To Pfizer's COVID-19 Pill Paxlovid",
                "features": {
                    "keywords": [
                        "EMA",
                        "Early",
                        "Access",
                        "Pfizer",
                        "COVID-19",
                        "Pill",
                        "Paxlovid"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-06",
                "original_text": "Small S.Africa patient study shows Omicron breaking through booster shots",
                "features": {
                    "keywords": [
                        "S.Africa",
                        "Patient",
                        "Study",
                        "Omicron",
                        "Booster",
                        "Shots"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-07",
                "original_text": "Pfizer Will Dominate $20 Billion Covid-Pill Market in 2022, Analysis Shows",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Dominate",
                        "Covid-Pill",
                        "Market",
                        "Analysis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}